CVS Health (NYSE: CVS) reported Q1 EPS of $1.33, $0.38 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $88.4 billion versus the consensus estimate of $89.33 billion.

GUIDANCE:

CVS Health sees FY2024 EPS of $7.00, versus the consensus of $8.28.

For earnings history and earnings-related data on CVS Health (CVS) click here.